Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs J B Hunt Transport Services Inc (JBHT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs J B Hunt Transport Services Inc — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while J B Hunt Transport Services Inc trades at $229.26 (market cap $21.45B). The key difference: J B Hunt Transport Services Inc is the larger of the two by market cap, and J B Hunt Transport Services Inc pays a 0.79% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and J B Hunt Transport Services Inc for 46 Days on average.
| HALO | JBHT | |
|---|---|---|
Market Cap | $12.58B | $21.45B |
Volume | 2,179,278 | 1,028,680 |
Sector | Health | Industrials |
52-Week High | $115.22 | $298.41 |
52-Week Low | $61.63 | $137.09 |
Typical Hold Time | 1 Days | 46 Days |
Enterprise Value | $14.49B | $22.59B |
Dividend Yield | — | 0.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
JBHT trades at $228.42, up 2.6% with strong earnings beats in recent quarters. Technical indicators show bearish momentum with support at $225 and resistance at $230. The company maintains solid fundamentals with $12B revenue, 5.31% net margin, and 18.45% ROE, though valuation metrics appear elevated with P/E of 32.5. Recent news highlights ongoing securities investigations and Q3 earnings anticipation.
Outlook remains cautiously optimistic with analyst consensus price target of $289.40 (27% upside) and 59% buy ratings. Key risks include legal investigations, cost pressures from diesel prices, and competitive trucking industry. Earnings growth and freight demand provide catalysts, but legal overhang warrants monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About J B Hunt Transport Services Inc
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).
Read more on JBHT →
